XML 68 R58.htm IDEA: XBRL DOCUMENT v3.22.2
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Earnings Per Share [Abstract]        
Net loss attributable to Adaptive Biotechnologies Corporation $ (52,046) $ (49,301) $ (114,782) $ (89,943)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 142,363,589 140,359,317 142,032,261 139,667,380
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.37) $ (0.35) $ (0.81) $ (0.64)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 142,363,589 140,359,317 142,032,261 139,667,380
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.37) $ (0.35) $ (0.81) $ (0.64)